Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra J Shin

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
American Journal of Clinical Pathology|August 16, 2015
Evaluating the utility of trefoil factor 1 as a mammary-specific immunostain compared and in conjunction with GATA-3 and mammaglobin in the distinction between carcinoma of breast and lungJustin M Wells, Paula S Ginter, Yifang Liu, et al.
The American Surgeon|February 1, 2014
Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancerStarr B Koslow, Rachel E K Eisenberg, Queenie Qiu, et al.
International Journal of Oncology|October 4, 2006
Reduced lecithin:retinol acyltransferase expression in human breast cancerMarni Sheren-Manoff, Sandra J Shin, Dan Su, et al.
World Journal of Surgical Oncology|November 17, 2005
Aberrant E-cadherin staining patterns in invasive mammary carcinomaMalini Harigopal, Sandra J Shin, Melissa P Murray, et al.
Archives of Pathology & Laboratory Medicine|January 22, 2015
Advocating Nonsurgical Management of Patients With Small, Incidental Radial Scars at the Time of Needle Core Biopsy: A Study of 77 CasesCathleen Matrai, Timothy M D'Alfonso, Lindsay Pharmer, et al.
Histopathology|November 7, 2015
Human epidermal growth factor receptor 2 testing in invasive breast cancer: should histological grade, type and oestrogen receptor status influence the decision to repeat testing?Emad A Rakha, Marian Pigera, Sandra J Shin, et al.
Clinical Breast Cancer|April 16, 2017
Folate Receptor Alpha Expression Is Associated With Increased Risk of Recurrence in Triple-negative Breast CancerPaula S Ginter, Patrick J McIntire, Xiaoyan Cui, et al.
Human Pathology|January 25, 2014
Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sitesPaula S Ginter, Juan Miguel Mosquera, Theresa Y MacDonald, et al.
The American Journal of Surgical Pathology|December 3, 2008
Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinomaSandra J Shin, Peter T Simpson, Leonard Da Silva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2015
National guidelines and level of evidence: comments on some of the new recommendations in the American Society of Clinical Oncology and the College of American Pathologists human epidermal growth factor receptor 2 guidelines for breast cancerEmad A Rakha, Marian Pigera, Abeer Shaaban, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
American Journal of Clinical Pathology|August 16, 2015
Evaluating the utility of trefoil factor 1 as a mammary-specific immunostain compared and in conjunction with GATA-3 and mammaglobin in the distinction between carcinoma of breast and lungJustin M Wells, Paula S Ginter, Yifang Liu, et al.
The American Surgeon|February 1, 2014
Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancerStarr B Koslow, Rachel E K Eisenberg, Queenie Qiu, et al.
International Journal of Oncology|October 4, 2006
Reduced lecithin:retinol acyltransferase expression in human breast cancerMarni Sheren-Manoff, Sandra J Shin, Dan Su, et al.
World Journal of Surgical Oncology|November 17, 2005
Aberrant E-cadherin staining patterns in invasive mammary carcinomaMalini Harigopal, Sandra J Shin, Melissa P Murray, et al.
Archives of Pathology & Laboratory Medicine|January 22, 2015
Advocating Nonsurgical Management of Patients With Small, Incidental Radial Scars at the Time of Needle Core Biopsy: A Study of 77 CasesCathleen Matrai, Timothy M D'Alfonso, Lindsay Pharmer, et al.
Histopathology|November 7, 2015
Human epidermal growth factor receptor 2 testing in invasive breast cancer: should histological grade, type and oestrogen receptor status influence the decision to repeat testing?Emad A Rakha, Marian Pigera, Sandra J Shin, et al.
Clinical Breast Cancer|April 16, 2017
Folate Receptor Alpha Expression Is Associated With Increased Risk of Recurrence in Triple-negative Breast CancerPaula S Ginter, Patrick J McIntire, Xiaoyan Cui, et al.
Human Pathology|January 25, 2014
Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sitesPaula S Ginter, Juan Miguel Mosquera, Theresa Y MacDonald, et al.
The American Journal of Surgical Pathology|December 3, 2008
Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinomaSandra J Shin, Peter T Simpson, Leonard Da Silva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2015
National guidelines and level of evidence: comments on some of the new recommendations in the American Society of Clinical Oncology and the College of American Pathologists human epidermal growth factor receptor 2 guidelines for breast cancerEmad A Rakha, Marian Pigera, Abeer Shaaban, et al.
Pageof 8